GB1547758A
(en)
|
1975-07-29 |
1979-06-27 |
Shell Int Research |
Herbicidal composition
|
US5411981A
(en)
|
1991-01-09 |
1995-05-02 |
Roussel Uclaf |
Phenylimidazolidines having antiandrogenic activity
|
FR2693461B1
(fr)
|
1992-07-08 |
1994-09-02 |
Roussel Uclaf |
Nouvelles phénylimidazolidines substituées, leur procédé de préparation, leur application comme médicaments et les compositions pharmaceutiques les renfermant.
|
US5589452A
(en)
|
1992-07-14 |
1996-12-31 |
Syntex (U.S.A.) Inc. |
Analogs of parathyroid hormone and parathyroid hormone related peptide: synthesis and use for the treatment of osteoporosis
|
GB9310635D0
(en)
|
1993-05-21 |
1993-07-07 |
Glaxo Group Ltd |
Chemical compounds
|
DE19517430A1
(de)
|
1995-05-12 |
1996-11-14 |
Boehringer Mannheim Gmbh |
Pharmazeutische Darreichungsform von Parathormon mit einer zwei- bis sechsstündigen Wirkstoff-Freisetzungsperiode
|
UA51652C2
(uk)
|
1995-06-08 |
2002-12-16 |
Новартіс Аг |
Спосіб гідрування імінів
|
US5723577A
(en)
|
1995-07-13 |
1998-03-03 |
Biomeasure Inc. |
Analogs of parathyroid hormone
|
US5969095A
(en)
|
1995-07-13 |
1999-10-19 |
Biomeasure, Inc. |
Analogs of parathyroid hormone
|
US5955574A
(en)
|
1995-07-13 |
1999-09-21 |
Societe De Conseils De Recherches Et D'applications Scientifiques, S.A. |
Analogs of parathyroid hormone
|
US7410948B2
(en)
|
1995-07-13 |
2008-08-12 |
Societe De Conseils De Recherches Et D'applications Scientifiques, Sas |
Analogs of parathyroid hormone
|
US6544949B1
(en)
|
1995-07-13 |
2003-04-08 |
Societe De Conseils De Recherches Et D'applications Scientifiques, S.A.S. |
Analogs of parathyroid hormone
|
AU728178B2
(en)
|
1996-06-27 |
2001-01-04 |
Ligand Pharmaceuticals Incorporated |
Androgen receptor modulator compounds and methods
|
US20090264534A1
(en)
|
1996-11-27 |
2009-10-22 |
Dalton James T |
Selective androgen receptor modulators
|
US6316408B1
(en)
|
1997-04-16 |
2001-11-13 |
Amgen Inc. |
Methods of use for osetoprotegerin binding protein receptors
|
FR2770842B1
(fr)
|
1997-11-13 |
1999-12-17 |
Oreal |
Nouveaux composes derives de n-aryl 2-hydroxy alkylamides
|
EP0922467A3
(en)
|
1997-12-12 |
2000-05-24 |
Takeda Chemical Industries, Ltd. |
Iontophoretic drug delivery
|
JP4154017B2
(ja)
|
1997-12-30 |
2008-09-24 |
久光製薬株式会社 |
イオントフォレーシス装置および薬物ユニット
|
US6159959A
(en)
|
1999-05-06 |
2000-12-12 |
American Home Products Corporation |
Combined estrogen and antiestrogen therapy
|
AU1280701A
(en)
|
1999-11-17 |
2001-05-30 |
Novartis Ag |
Iontophoretic transdermal delivery of peptides
|
US6544553B1
(en)
|
1999-12-28 |
2003-04-08 |
Watson Pharmaceuticals, Inc. |
Dosage forms and methods for oral delivery of progesterone
|
PT1246814E
(pt)
|
1999-12-30 |
2005-07-29 |
Signal Pharm Llc |
Compostos e metodos para a modulacao de receptores de estrgenio
|
IL152719A0
(en)
|
2000-06-28 |
2003-06-24 |
Bristol Myers Squibb Co |
Selective androgen receptor modulators and methods for their identification
|
AU2001282064B2
(en)
|
2000-08-03 |
2007-02-01 |
Antares Pharma Ipl Ag |
Novel composition for transdermal and/or transmucosal administration of active compounds that ensures adequate therapeutic levels
|
AU2006201538B2
(en)
|
2000-08-24 |
2008-02-21 |
University Of Tennessee Research Foundation |
Selective androgen receptor modulators and methods of use thereof
|
PT1491524E
(pt)
|
2000-08-24 |
2009-04-16 |
Univ Tennessee Res Foundation |
Moduladores selectivos do receptor androgénico e processos para a sua utilização
|
US7371721B2
(en)
|
2000-09-18 |
2008-05-13 |
Sanos Bioscience A/S |
Use of GLP-2 and related compounds for the treatment, prevention, diagnosis, and prognosis of bone-related disorders and calcium homeostasis related syndromes
|
US7186683B2
(en)
|
2000-09-18 |
2007-03-06 |
Sanos Bioscience A/S |
Use of GLP for the treatment, prevention, diagnosis, and prognosis of bone-related and nutrition-related disorders
|
BR0114909A
(pt)
|
2000-10-26 |
2004-02-03 |
Alza Corp |
Dispositivos de distribuição de drogas transdérmicas possuindo microprotuberâncias revestidas
|
US6670386B2
(en)
|
2001-07-31 |
2003-12-30 |
Bristol-Myers Squibb Company |
Bicyclic modulators of androgen receptor function
|
US7157604B2
(en)
|
2001-08-13 |
2007-01-02 |
Merck & Co., Inc. |
Selective estrogen receptor modulators
|
US8853266B2
(en)
|
2001-12-06 |
2014-10-07 |
University Of Tennessee Research Foundation |
Selective androgen receptor modulators for treating diabetes
|
WO2003063859A1
(en)
|
2002-01-14 |
2003-08-07 |
Nordic Bioscience A/S |
Suppression of cartilage degradation via the estrogen receptor
|
AU2003205461B2
(en)
|
2002-02-15 |
2006-08-31 |
Endorecherche, Inc. |
Biphenyl Derivatives and their Use as Antiandrogenic Agents
|
US7772433B2
(en)
|
2002-02-28 |
2010-08-10 |
University Of Tennessee Research Foundation |
SARMS and method of use thereof
|
US7138426B2
(en)
|
2002-04-24 |
2006-11-21 |
Merck & Co., Inc. |
Estrogen receptor modulators
|
TW200407324A
(en)
|
2002-05-17 |
2004-05-16 |
Bristol Myers Squibb Co |
Bicyclic modulators of androgen receptor function
|
US7906480B2
(en)
|
2002-05-23 |
2011-03-15 |
Michael Holick |
Use of a parathyroid hormone peptide analogs for the treatment of vaginal atrophy
|
TW200307553A
(en)
|
2002-05-24 |
2003-12-16 |
Akzo Nobel Nv |
Treatment of post-menopausal complaints in breast cancer patients
|
WO2003105772A2
(en)
|
2002-06-13 |
2003-12-24 |
Beth Israel Deaconess Medical Center, Inc. |
Analogs of parathyroid hormone and pth-related protein as bone anabolic agents
|
JP4449746B2
(ja)
|
2002-07-12 |
2010-04-14 |
アステラス製薬株式会社 |
N−フェニル−(2r,5s)ジメチルピペラジン誘導体
|
AU2003254993A1
(en)
|
2002-08-12 |
2004-03-03 |
Takeda Pharmaceutical Company Limited |
Fused benzene derivative and use
|
US7383084B2
(en)
|
2002-10-31 |
2008-06-03 |
Transpharma Medical Ltd. |
Transdermal delivery system for dried particulate or lyophilized medications
|
US8133505B2
(en)
|
2002-10-31 |
2012-03-13 |
Transpharma Medical Ltd. |
Transdermal delivery system for dried particulate or lyophilized medications
|
IL152574A
(en)
|
2002-10-31 |
2009-09-22 |
Transpharma Medical Ltd |
A system for passing through the skin of dry items or dried medicines
|
US7662404B2
(en)
|
2002-10-31 |
2010-02-16 |
Transpharma Medical Ltd. |
Transdermal delivery system for dried particulate or lyophilized peptides and polypeptides
|
EP1581217A4
(en)
|
2002-11-01 |
2007-07-11 |
Merck & Co Inc |
CARBONYLAMINO-BENZIMIDAZOLE DERIVATIVES AS MODULATORS OF THE ANDROGEN RECEPTOR
|
UA79504C2
(en)
|
2002-11-07 |
2007-06-25 |
Organon Nv |
Indols for treating diseases associated with androgen receptors
|
AU2003302084A1
(en)
|
2002-11-15 |
2004-06-15 |
Bristol-Myers Squibb Company |
Open chain prolyl urea-related modulators of androgen receptor function
|
JP4500689B2
(ja)
|
2002-12-26 |
2010-07-14 |
エーザイ・アール・アンド・ディー・マネジメント株式会社 |
選択的エストロゲン受容体モジュレーター
|
EP1603858A2
(en)
|
2003-03-11 |
2005-12-14 |
NeuroSearch A/S |
Kcnq channel modulating compounds and their pharmaceutical use
|
US7517529B2
(en)
*
|
2003-04-08 |
2009-04-14 |
Biotempt B.V. |
Treatment of type I diabetes
|
JP2007500245A
(ja)
|
2003-06-10 |
2007-01-11 |
スミスクライン ビーチャム コーポレーション |
化合物
|
JP2007505164A
(ja)
|
2003-06-10 |
2007-03-08 |
スミスクライン ビーチャム コーポレーション |
アンドロゲン、グルココルチコイド、ミネラルコルチコイドおよびプロゲステロン受容体のモジュレーターとしての1−アミノナフタレン類
|
WO2005000309A2
(en)
|
2003-06-27 |
2005-01-06 |
Ionix Pharmaceuticals Limited |
Chemical compounds
|
FI20030958A0
(fi)
|
2003-06-27 |
2003-06-27 |
Orion Corp |
Uusia yhdisteitä
|
JP5456234B2
(ja)
|
2003-06-30 |
2014-03-26 |
アルザ・コーポレーシヨン |
非揮発性の対イオンを含有する被覆された微小突起のための製剤
|
CA2531136A1
(en)
|
2003-07-04 |
2005-01-13 |
Nycomed Danmark Aps |
Parathyroid hormone (pth) containing pharmaceutical compositions for oral use
|
US7446110B2
(en)
|
2003-09-10 |
2008-11-04 |
Merck & Co., Inc. |
17-Heterocyclic-4-azasteroid derivatives as androgen receptor modulators
|
US20050124625A1
(en)
|
2003-10-21 |
2005-06-09 |
Salvati Mark E. |
Piperazine derivatives and their use as modulators of nuclear hormone receptor function
|
GB0324551D0
(en)
|
2003-10-21 |
2003-11-26 |
Karobio Ab |
Novel compounds
|
BRPI0415629A
(pt)
|
2003-10-31 |
2006-12-12 |
Alza Corp |
aplicador auto-atuador para conjunto de microprojeções
|
WO2005051456A2
(en)
|
2003-11-13 |
2005-06-09 |
Alza Corporation |
Composition and apparatus for transdermal delivery
|
US7256208B2
(en)
|
2003-11-13 |
2007-08-14 |
Bristol-Myers Squibb Company |
Monocyclic N-Aryl hydantoin modulators of androgen receptor function
|
CA2545048A1
(en)
|
2003-11-20 |
2005-06-02 |
Warner-Lambert Company Llc |
Androgen receptor modulators
|
IL159273A0
(en)
|
2003-12-09 |
2004-06-01 |
Transpharma Medical Ltd |
Transdermal delivery system for sustained release of polypeptides
|
AU2003297904A1
(en)
|
2003-12-12 |
2005-07-14 |
University Of Maryland, Baltimore |
Immunomodulatory compounds that target and inhibit the py+3 binding site of tyrosene kinase p56 lck sh2 domain
|
RU2397176C2
(ru)
|
2004-01-07 |
2010-08-20 |
Эндорешерш, Инк. |
Стероидные фармацевтические продукты, направленные на спираль 12
|
KR100849559B1
(ko)
|
2004-01-22 |
2008-07-31 |
일라이 릴리 앤드 캄파니 |
혈관운동 증상의 치료를 위한 선택적 에스트로겐 수용체조절제
|
IL160033A0
(en)
|
2004-01-25 |
2004-06-20 |
Transpharma Medical Ltd |
Transdermal delivery system for polynucleotides
|
US7820702B2
(en)
|
2004-02-04 |
2010-10-26 |
Bristol-Myers Squibb Company |
Sulfonylpyrrolidine modulators of androgen receptor function and method
|
US20050182105A1
(en)
|
2004-02-04 |
2005-08-18 |
Nirschl Alexandra A. |
Method of using 3-cyano-4-arylpyridine derivatives as modulators of androgen receptor function
|
WO2005085185A1
(en)
|
2004-03-03 |
2005-09-15 |
Smithkline Beecham Corporation |
Aniline derivatives as selective androgen receptor modulators
|
US7696241B2
(en)
|
2004-03-04 |
2010-04-13 |
Bristol-Myers Squibb Company |
Bicyclic compounds as modulators of androgen receptor function and method
|
US7388027B2
(en)
|
2004-03-04 |
2008-06-17 |
Bristol-Myers Squibb Company |
Bicyclic compounds as modulators of androgen receptor function and method
|
US7625923B2
(en)
|
2004-03-04 |
2009-12-01 |
Bristol-Myers Squibb Company |
Bicyclic modulators of androgen receptor function
|
GB0405033D0
(en)
|
2004-03-05 |
2004-04-07 |
Karobio Ab |
Novel pharmaceutical compositions
|
WO2005090282A1
(en)
|
2004-03-12 |
2005-09-29 |
Ligand Pharmaceuticals Incorporated |
Androgen receptor modulator compounds and methods
|
JP2007223901A
(ja)
|
2004-03-24 |
2007-09-06 |
Takeda Chem Ind Ltd |
複素環化合物およびその用途
|
AU2005232619B2
(en)
|
2004-04-08 |
2008-07-24 |
Merck Sharp & Dohme Corp. |
17 beta-acetamide-4-azasteroids as androgen receptor modulators
|
TW200602317A
(en)
|
2004-04-23 |
2006-01-16 |
Akzo Nobel Nv |
Novel androgens
|
US7282507B2
(en)
|
2004-05-03 |
2007-10-16 |
Janssen Pharmaceutica N.V. |
Indole derivatives as selective androgen receptor modulators (SARMS)
|
CA2565205A1
(en)
|
2004-05-03 |
2005-11-24 |
Janssen Pharmaceutica N.V. |
Benzofuran derivatives as selective androgen receptor modulators (sarms)
|
WO2005108351A1
(en)
|
2004-05-11 |
2005-11-17 |
Pfizer Products Inc. |
Benzonitrile derivatives to treat musculoskeletal frailty
|
CA2566032A1
(en)
|
2004-05-13 |
2005-12-01 |
Alza Corporation |
Apparatus and method for transdermal delivery of parathyroid hormone agents
|
AU2005247405A1
(en)
|
2004-05-17 |
2005-12-08 |
Acadia Pharmaceuticals Inc. |
Androgen receptor modulators and method of treating disease using the same
|
BRPI0511671A
(pt)
|
2004-05-29 |
2008-01-02 |
7Tm Pharma As |
tiazolacético substituìdo como ligantes de crth2
|
EP1753417B1
(en)
|
2004-06-07 |
2012-04-04 |
University Of Tennessee Research Foundation |
A selective androgen receptor modulator and medical uses thereof
|
AU2005285035B2
(en)
|
2004-09-10 |
2012-03-22 |
Janssen Pharmaceutica N.V. |
Novel imidazolidin-2-one derivatives as selective androgen receptor modulators (SARMS)
|
JP5031570B2
(ja)
|
2004-09-20 |
2012-09-19 |
ジヤンセン・フアーマシユーチカ・ナームローゼ・フエンノートシヤツプ |
性ステロイドホルモン受容体モジュレーターとして有用な新規な四環式ヘテロ原子含有誘導体
|
CN101065363B
(zh)
|
2004-09-30 |
2012-05-02 |
詹森药业有限公司 |
可用作选择性雄激素受体调节剂(sarms)的新苯并咪唑衍生物
|
US8143425B2
(en)
|
2004-10-12 |
2012-03-27 |
Bristol-Myers Squibb Company |
Heterocyclic aromatic compounds useful as growth hormone secretagogues
|
EP1809275A1
(en)
|
2004-10-13 |
2007-07-25 |
Smithkline Beecham Corporation |
Chemical compounds
|
US20080124402A1
(en)
|
2004-10-29 |
2008-05-29 |
Merck & Co., Inc. |
N-(Pyridin-3-Yl)-2-Phenylbutanamides As Androgen Receptor Modulators
|
WO2006055184A2
(en)
|
2004-11-16 |
2006-05-26 |
Janssen Pharmaceutica N.V. |
Novel heterocycle derivatives useful as selective androgen receptor modulators (sarms)
|
CA2587780A1
(en)
|
2004-11-18 |
2006-05-26 |
Transpharma Medical Ltd. |
Combined micro-channel generation and iontophoresis for transdermal delivery of pharmaceutical agents
|
EP1817025A2
(en)
|
2004-11-23 |
2007-08-15 |
PTC Therapeutics, Inc. |
Tetrahydrocarbazoles as active agents for inhibiting vegf production by translational control
|
EP1836202B1
(en)
|
2005-01-10 |
2016-12-21 |
Acadia Pharmaceuticals Inc. |
Aminophenyl derivatives as selective androgen receptor modulators
|
EP1871379A4
(en)
|
2005-04-15 |
2010-06-02 |
Glaxosmithkline Llc |
CYANOARYLAMINE
|
JP5089578B2
(ja)
|
2005-05-13 |
2012-12-05 |
イーライ リリー アンド カンパニー |
選択的なアンドロゲン受容体調節物質としての置換型n−アリールピロリジン
|
EP1888512A2
(en)
|
2005-06-06 |
2008-02-20 |
Smithkline Beecham Corporation |
Chemical compounds
|
US7829589B2
(en)
|
2005-06-10 |
2010-11-09 |
Elixir Pharmaceuticals, Inc. |
Sulfonamide compounds and uses thereof
|
US7709516B2
(en)
|
2005-06-17 |
2010-05-04 |
Endorecherche, Inc. |
Helix 12 directed non-steroidal antiandrogens
|
JP5204650B2
(ja)
|
2005-06-24 |
2013-06-05 |
イーライ リリー アンド カンパニー |
アンドロゲン受容体調節物質として有用なテトラヒドロカルバゾール誘導体
|
US20090227571A1
(en)
|
2005-07-01 |
2009-09-10 |
Ligand Pharmaceuticals Incorporated |
Androgen Receptor Modulator Compounds and Methods
|
EP1911743B8
(en)
|
2005-08-01 |
2013-01-16 |
Takeda Pharmaceutical Company Limited |
Cyclic amine compound
|
JP2008303145A
(ja)
|
2005-09-22 |
2008-12-18 |
Takeda Chem Ind Ltd |
Grk阻害剤からなる強心薬
|
US7776859B2
(en)
|
2005-10-14 |
2010-08-17 |
Bristol-Myers Squibb Company |
Hexahydroimidazopyrazin-3-one compounds useful as modulators of androgen receptor function
|
JP5449775B2
(ja)
*
|
2005-10-19 |
2014-03-19 |
チャバフ ピーティーワイ エルティーディー |
乳癌の治療に使用されるアロマターゼ阻害薬による副作用の低減
|
WO2007061964A1
(en)
|
2005-11-18 |
2007-05-31 |
3M Innovative Properties Company |
Methods for coating microneedles
|
TW200730505A
(en)
|
2005-12-07 |
2007-08-16 |
Merck & Co Inc |
Polymorphs of an androgen receptor modulator
|
EP1981547B1
(en)
|
2005-12-28 |
2015-09-30 |
Alza Corporation |
Stable therapeutic formulations
|
AU2007208139B2
(en)
|
2006-01-24 |
2012-09-27 |
Janssen Pharmaceutica N.V. |
2-substituted benzimidazoles as selective androgen receptor modulators (sarms)
|
NZ570533A
(en)
|
2006-03-03 |
2011-02-25 |
Orion Corp |
Compounds useful as Selective androgen receptor modulators (SARM), in particular (2S)-3-(4-cyano-3-fluorophenoxy)-N-(4-cyano-3-methylphenyl)-2-hydroxy-2-methylpropionamide useful in hormonal therapy
|
CN101466393A
(zh)
|
2006-03-15 |
2009-06-24 |
阿尔扎公司 |
用于经皮递送甲状旁腺激素药剂以治疗骨质减少的方法
|
WO2007124411A1
(en)
|
2006-04-20 |
2007-11-01 |
3M Innovative Properties Company |
Device for applying a microneedle array
|
EP2037905B1
(en)
|
2006-06-23 |
2013-05-01 |
Radius Health, Inc. |
Treatment of vasomotor symptoms with selective estrogen receptor modulators
|
EA018258B1
(ru)
|
2006-07-12 |
2013-06-28 |
Юниверсити Оф Теннесси Рисерч Фаундейшн |
Замещенный ациланилид и содержащие его композиции и способы лечения
|
MX2009000715A
(es)
|
2006-07-19 |
2009-07-22 |
Osurf Ohio State University Re |
Moduladores de receptor de androgeno selectivos, analogos y derivados de los mismos.
|
PT2054049E
(pt)
|
2006-08-24 |
2016-06-02 |
Univ Tennessee Res Found |
Acilanilidas substituídas e métodos de utilização das mesmas
|
WO2008042571A2
(en)
|
2006-09-29 |
2008-04-10 |
Smithkline Beecham Corporation |
Substituted indole compounds
|
US7803770B2
(en)
|
2006-10-03 |
2010-09-28 |
Radius Health, Inc. |
Method of treating osteoporosis comprising administration of PTHrP analog
|
AU2007322334B2
(en)
|
2006-10-03 |
2011-12-22 |
Ipsen Pharma S.A.S. |
Method of drug delivery for bone anabolic protein
|
WO2008044033A1
(en)
|
2006-10-11 |
2008-04-17 |
Astrazeneca Ab |
Amide derivatives
|
UA98777C2
(en)
|
2006-11-20 |
2012-06-25 |
Эли Лилли Энд Компани |
Tetrahydrocyclopenta[b]indole compounds as androgen receptor modulators
|
WO2008121602A1
(en)
|
2007-03-29 |
2008-10-09 |
Smithkline Beecham Corporation |
Chemical compounds
|
WO2008124000A2
(en)
|
2007-04-02 |
2008-10-16 |
Ligand Pharmaceuticals Incorporated |
Thiazole derivatives as androgen receptor modulator compounds
|
US9284345B2
(en)
|
2007-04-12 |
2016-03-15 |
Endorecherche, Inc. |
17alpha-substituted steroids as systemic antiandrogens and selective androgen receptor modulators
|
WO2008128100A1
(en)
|
2007-04-13 |
2008-10-23 |
The Regents Of The University Of California |
Small-molecule inhibitors of the androgen receptor
|
AU2008241470B2
(en)
|
2007-04-16 |
2013-11-07 |
Corium Pharma Solutions, Inc. |
Solvent-cast microneedle arrays containing active
|
GB0712099D0
(en)
|
2007-06-22 |
2007-08-01 |
Wivenhoe Technology Ltd |
Transmission Of Audio Information
|
MX2010001484A
(es)
|
2007-08-07 |
2010-03-04 |
Takeda Pharmaceutical |
Derivados de pirrolidin-2-ona como moduladores del receptor de androgeno.
|
WO2009054988A1
(en)
|
2007-10-23 |
2009-04-30 |
Alza Corporation |
Transdermal sustained release drug delivery
|
US20110105554A1
(en)
|
2007-11-21 |
2011-05-05 |
Kinaris Biomedicals Gmbh |
Means for treating myosin-related diseases
|
EP2235010A1
(en)
|
2007-12-21 |
2010-10-06 |
AstraZeneca AB |
Bicyclic derivatives for use in the treatment of androgen receptor associated conditions
|
PL2222636T3
(pl)
|
2007-12-21 |
2014-04-30 |
Ligand Pharm Inc |
Selektywne modulatory receptorów androgenowych (SARM) i ich zastosowania
|
CA2716320C
(en)
|
2008-02-22 |
2014-01-28 |
Radius Health, Inc. |
Selective androgen receptor modulators
|
US8268872B2
(en)
|
2008-02-22 |
2012-09-18 |
Radius Health, Inc. |
Selective androgen receptor modulators
|
WO2009133861A1
(ja)
|
2008-04-28 |
2009-11-05 |
武田薬品工業株式会社 |
環状アミン化合物
|
WO2009137104A1
(en)
|
2008-05-09 |
2009-11-12 |
Radius Health, Inc. |
Combination therapy for breastcancer comprising an antiestrogenic agent
|
DK2297100T3
(da)
|
2008-05-16 |
2012-12-17 |
Lilly Co Eli |
Tetrahydrocyclopenta[b]indol-androgenreceptor-modulatorer
|
WO2010022176A1
(en)
|
2008-08-19 |
2010-02-25 |
Ferring International Center S.A. |
Methods of treatment for skeletal conditons
|
KR101634836B1
(ko)
|
2008-12-26 |
2016-06-29 |
히사미쓰 세이야꾸 가부시키가이샤 |
마이크로 니들 디바이스
|
EP2384320B1
(en)
|
2009-01-05 |
2015-03-04 |
Boehringer Ingelheim International GmbH |
Pyrrolidine compounds which modulate the cb2 receptor
|
US20100226966A1
(en)
|
2009-03-03 |
2010-09-09 |
Daddona Peter E |
Method for transdermal controlled release drug delivery
|
WO2010118287A1
(en)
|
2009-04-10 |
2010-10-14 |
Radius Health, Inc. |
Selective androgen receptor modulators
|
DK2433940T3
(en)
|
2009-04-28 |
2015-01-12 |
Chugai Pharmaceutical Co Ltd |
Spiroimidazolonderivat
|
US20110172609A1
(en)
|
2010-01-08 |
2011-07-14 |
Ratio, Inc. |
Microneedle component assembly for drug delivery device
|
CA2788907A1
(en)
|
2010-02-04 |
2011-08-11 |
Radius Health, Inc. |
Selective androgen receptor modulators
|
IE20100174A1
(en)
|
2010-03-25 |
2012-02-29 |
Trinity College Dublin |
Transdermal administration of peptides
|
JP5606778B2
(ja)
|
2010-04-22 |
2014-10-15 |
大倉工業株式会社 |
手術用資材
|
ES2719595T3
(es)
|
2010-05-04 |
2019-07-11 |
Corium Int Inc |
Método y dispositivo para la administración transdérmica de la hormona paratiroidea usando una matriz de microproyección
|
MX342898B
(es)
|
2010-05-12 |
2016-10-18 |
Radius Health Inc * |
Regimen terapéutico de la sal de diclorhidrato del (r) -6-(2-(etil (4-2(etilamino) etil) bencil) amino)-4-metoxifenil)-5, 6,7,8-tetrahidronaftaleno-2-ol.
|
AU2011258288B2
(en)
|
2010-05-28 |
2015-02-12 |
Kindeva Drug Delivery L.P. |
Aqueous formulations for coating microneedle arrays
|
US8642632B2
(en)
*
|
2010-07-02 |
2014-02-04 |
Radius Health, Inc. |
Selective androgen receptor modulators
|
BR112013007685B1
(pt)
|
2010-09-28 |
2021-11-09 |
Radius Pharmaceuticals, Inc |
Compostos moduladores de receptor andrógeno seletivos, composição farmacêutica compreendendo os referidos compostos, método de identificação de um composto capaz de modular um receptor andrógeno, usos de um composto ou da composição e processo para a preparação de um composto
|
WO2012075375A1
(en)
|
2010-12-02 |
2012-06-07 |
Lanco Biosciences, Inc. |
Delivery of parathyroid hormones by microinjection systems
|
SG194570A1
(en)
|
2011-04-22 |
2013-12-30 |
Radius Health Inc |
Method of drug delivery for pth, pthrp and related peptides
|
WO2013082418A1
(en)
|
2011-11-30 |
2013-06-06 |
3M Innovative Properties Company |
Microneedle device having a peptide therapeutic agent and an amino acid, methods of making and using the same
|
US9622992B2
(en)
*
|
2012-07-13 |
2017-04-18 |
Gtx, Inc. |
Method of treating androgen receptor (AR)-positive breast cancers with selective androgen receptor modulator (SARMs)
|
US9744149B2
(en)
*
|
2012-07-13 |
2017-08-29 |
Gtx, Inc. |
Method of treating androgen receptor (AR)-positive breast cancers with selective androgen receptor modulator (SARMs)
|
US9969683B2
(en)
|
2012-07-13 |
2018-05-15 |
Gtx, Inc. |
Method of treating estrogen receptor (ER)-positive breast cancers with selective androgen receptor modulator (SARMS)
|
US10258596B2
(en)
*
|
2012-07-13 |
2019-04-16 |
Gtx, Inc. |
Method of treating HER2-positive breast cancers with selective androgen receptor modulators (SARMS)
|
AU2013352406A1
(en)
*
|
2012-11-28 |
2015-06-04 |
Novartis Ag |
Combination therapy
|
KR20160018534A
(ko)
|
2013-06-11 |
2016-02-17 |
바이엘 파마 악티엔게젤샤프트 |
Mps-1 키나제 억제제 및 유사분열 억제제를 포함하는 암의 치료를 위한 조합물
|
AU2014281464B2
(en)
*
|
2013-06-19 |
2019-09-26 |
University Of Miami |
Classification system, methods and kit for classifying, predicting and treating breast cancer
|